Original Peptide Drugs (e.g., Evodin, Pineamin)

About GEROPHARM

GEROPHARM has evolved from a domestic player into a significant, vertically integrated biotech company and the market leader for insulin in Russia. Its strategy is built on mastering complex biotechnologies, particularly for insulin and biosimilars, and expanding its international footprint through exports and local production partnerships. With over $160 million invested in R&D and innovation in the past decade and two major manufacturing sites, the company is positioned to capitalize on import substitution policies and growing demand in emerging markets.

Therapeutic Areas